[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![FinanceShyamal Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1733133568451522560.png) Shyamal Kumar Maity 🇮🇳 [@FinanceShyamal](/creator/twitter/FinanceShyamal) on x XXX followers
Created: 2025-07-19 01:50:26 UTC

Anthem Biosciences leads the pack with XXXX% EBITDA and XXXX% net margin—crushing Syngene, Sai, and even Divi’s Labs. Its RoE (18.7%) and RoCE (26.5%) scream efficiency,but a P/E of 70.9x raises eyebrows. Is this the next biotech marvel—or an overhyped valuation trap in disguise?

![](https://pbs.twimg.com/media/GwL0wzzWkAA9Iwk.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946387121390149683/c:line.svg)

**Related Topics**
[trap](/topic/trap)

[Post Link](https://x.com/FinanceShyamal/status/1946387121390149683)